Order Article Reprints

Shkodra B, Press AT, Vollrath A, Nischang I, Schubert S, Hoeppener S, Haas D, Enzensperger C, Lehmann M, Babic P, et al. Formulation of Liver-Specific PLGA-DY-635 Nanoparticles Loaded with the Protein Kinase C Inhibitor Bisindolylmaleimide I. Pharmaceutics. 2020; 12(11):1110. https://doi.org/10.3390/pharmaceutics12111110

Shkodra, Blerina, Adrian T. Press, Antje Vollrath, Ivo Nischang, Stephanie Schubert, Stephanie Hoeppener, Dorothee Haas, Christoph Enzensperger, Marc Lehmann, Petra Babic, and et al. 2020. "Formulation of Liver-Specific PLGA-DY-635 Nanoparticles Loaded with the Protein Kinase C Inhibitor Bisindolylmaleimide I" Pharmaceutics 12, no. 11: 1110. https://doi.org/10.3390/pharmaceutics12111110

Shkodra, B., Press, A. T., Vollrath, A., Nischang, I., Schubert, S., Hoeppener, S., Haas, D., Enzensperger, C., Lehmann, M., Babic, P., Benecke, K. J., Traeger, A., Bauer, M., & Schubert, U. S. (2020). Formulation of Liver-Specific PLGA-DY-635 Nanoparticles Loaded with the Protein Kinase C Inhibitor Bisindolylmaleimide I. Pharmaceutics, 12(11), 1110. https://doi.org/10.3390/pharmaceutics12111110